Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteoporosis in Post-menopausal Women”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Large-scale testing (Phase 3)Study completedNCT01806792
What this trial is testing

Post-menopausal Women Osteoporosis(Phase III)

Who this might be right for
Postmenopausal Women Osteoporosis
Hanlim Pharm. Co., Ltd. 150
Not applicableStudy completedNCT03337971
What this trial is testing

Nutritional Supplement and Bone Health in Post-Menopausal Women

Who this might be right for
Bone and BonesOsteoporosis RiskOsteoporosis, Postmenopausal
University of Limerick 16
Post-approval studies (Phase 4)Study completedNCT00503113
What this trial is testing

Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 801
Post-approval studies (Phase 4)Looking for participantsNCT06864130
What this trial is testing

A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures

Who this might be right for
Osteoporosis in Post-menopausal Women
Odense University Hospital 1,400
Large-scale testing (Phase 3)Study completedNCT00420940
What this trial is testing

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Who this might be right for
Bone DensityOsteopeniaOsteoporosis+1 more
University Health Network, Toronto 202
Post-approval studies (Phase 4)Study completedNCT00927186
What this trial is testing

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Who this might be right for
Osteoporosis, Post-menopausal
Eli Lilly and Company 69
Testing effectiveness (Phase 2)Study completedNCT00165204
What this trial is testing

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Who this might be right for
MenopausePostmenopausal Bone LossBreast Cancer
Dana-Farber Cancer Institute 50
Large-scale testing (Phase 3)Study completedNCT02186600
What this trial is testing

Heartland Osteoporosis Prevention Study

Who this might be right for
Osteopenia
University of Nebraska 276
Early research (Phase 1)Ended earlyNCT02337387
What this trial is testing

2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 28
Large-scale testing (Phase 3)Study completedNCT00172081
What this trial is testing

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Shire 2,532
Early research (Phase 1)UnknownNCT03242512
What this trial is testing

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Who this might be right for
Osteoporosis
Jiangsu T-Mab Biopharma Co.,Ltd 24
Post-approval studies (Phase 4)Study completedNCT01732770
What this trial is testing

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Amgen 643
Early research (Phase 1)Study completedNCT01224717
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

Who this might be right for
Post-menopausal Osteoporosis
Novartis 104
Post-approval studies (Phase 4)Study completedNCT00545909
What this trial is testing

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 585
Post-approval studies (Phase 4)Study completedNCT00532545
What this trial is testing

Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 45
Large-scale testing (Phase 3)Study completedNCT00543023
What this trial is testing

The Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 104
Post-approval studies (Phase 4)Study completedNCT02598934
What this trial is testing

Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 308
Not applicableUnknownNCT03382366
What this trial is testing

Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women

Who this might be right for
SarcopeniaFalls PatientOsteoporosis, Postmenopausal
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 40
Post-approval studies (Phase 4)Study completedNCT00545363
What this trial is testing

Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 716
Not applicableStudy completedNCT03701113
What this trial is testing

Milk Protein and Bone Health in Postmenopausal Women

Who this might be right for
Bone and BonesOsteoporosis RiskOsteoporosis, Postmenopausal
University of Limerick 64
Load More Results